cancer
Conditions
Interventions
Observation group:None
Sponsors
General Hospital of Xuzhou Mining Group
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 years and older with a diagnosis of malignant tumors who are undergoing chemotherapy regimens with a high/medium risk of vomiting; 2. Use of palonosetron hydrochloride as part of the antiemetic regimen; 3. Expected survival duration of 3 months or more; 4. Signed informed consent.
Exclusion criteria
Exclusion criteria: 1. The presence of other diseases affecting the assessment of nausea and vomiting (such as gastrointestinal obstruction, brain metastasis, active gastric ulcer, etc.); 2. Use of other antiemetic medications within one week prior to chemotherapy; 3. Pregnant or breastfeeding women; 4. Patients with mental cognitive disorders; 5. Other conditions deemed unsuitable for participation in the study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete relief rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Complete control rate;Functional Living Index–Emesis (FLIE) Scores;Frequency of vomiting;The timing and duration of each vomiting episode;The severity of nausea;The emergency medicine used;adverse event; | — |
Countries
China
Contacts
Public ContactBaoqing Wang
General Hospital of Xuzhou Mining Group
Outcome results
None listed